Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 3, 2008, Pages 223-230

  Gazi, Irene F ^a   Milionis, Haralampos J ^a   Filippatos, Theodosios D ^a   Tsimihodimos, Vasilis ^a   Kostapanos, Michael S ^a   Doumas, Michael ^a   Tselepis, Alexandros D ^b   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

LDL particle size; Metabolic triad; Small dense LDL; Triglycerides; Waist circumference

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FEMALE; GREECE; HUMAN; HYPERINSULINEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PARTICLE SIZE; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

APOLIPOPROTEINS B; BLOOD PRESSURE; BODY SIZE; CHOLESTEROL; FEMALE; GREECE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; LIPOPROTEINS, LDL; PATIENT SELECTION; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; TRIGLYCERIDES;

EID: 40749143515     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.784     Document Type: Article

References (21)

1. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184.
2. LaMonte MJ, Ainsworth BE, DuBose KD, et al. The hypertriglyceridemic waist phenotype among women. Atherosclerosis 2003; 171: 123-130.
3. Bos G, Dekker JM, Heine RJ. Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor: the Hoorn study. Diabetes Care 2004; 27: 283-284.
4. Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005; 111: 1883-1890.
5. Pollex RL, Hanley AJ, Zinman B, Harris SB, Hegele RA. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population. Int J Obes (Lond) 2006; 30: 484-491.
6. Lamarche B, Tchernof A, Mauriege P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961.
7. St-Pierre AC, Cantin B, Dagenais GR, et al. Low-density lipoprotein subfractions and the long term risk of ischemic heart disease in men. 13-year follow-up from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005; 25: 553-559.
8. Gazi IF, Filippatos TD, Tsimihodimos V, et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids 2006; 41: 647-654.
9. Hoefner DM, Hodel SD, O'Brien JF, et al. Development of a rapid, quantitative method for the LDL subfractionation with the use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001; 47: 266-274.
10. Kapantais E, Tzotzas T, Ioannidis I, et al. First national epidemiological survey on the prevalence of obesity and abdominal fat distribution in Greek adults. Ann Nutr Metab 2006; 50: 330-338.
11. Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma. Clin Chem 2005; 51: 2264-2273.
12. Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism 2006; 55: 885-891.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-2497.
14. Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 2004; 42: 1355-1363.
15. Gazi IF, Tsimihodimos V, Tselepis AD, Elisaf M, Mikhailidis DP. Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin Biol Ther 2007; 7: 53-72.
16. Ensign W, Hill N, Heward CB. Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. Clin Chem 2006; 52: 1722-1727.
17. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
18. Barter PJ, Ballantyne CM, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006; 259: 247-258.
19. Lamarche B, Moorjani S, Lupien PJ, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273-278.
20. Lemieux I, Almeras N, Mauriege P, et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18: 725-732.
21. St-Pierre J, Lemieux I, Vohl MC, et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 2002; 90: 15-18.